drugset / Trial / NCT03693404

Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery

NCT03693404

Phase 4 Completed 190 enrolled NYU Langone Health
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a phase I, randomized, single-blind, placebo-controlled, single-center study of the effects of surgical site injection on pain and narcotic utilization in participants who undergo surgery for lower extremity fractures. 200 participants with lower extremity fractures who are admitted for operative fixation will be included in the study. Participants will be randomized to receive either a pain cocktail injection around the fracture site and surrounding tissues or control (no injection). An analysis of pain scores, rehabilitation progress, length of stay, narcotic utilization, and satisfaction scores will be performed.

Timeline

Start
2018-12-01
Primary completion
2021-06-05
Completion
2021-06-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Subject Bupivacaine Other / unclassified 10 ml Other
Subject Bupivacaine Other / unclassified 40 ml Other
Subject Ketorolac Other / unclassified 30 mg Other
Subject Morphine Other / unclassified 5 mg Other

Indications

No indication recorded.